222 related articles for article (PubMed ID: 20660733)
1. Separating mitogenic and metabolic activities of fibroblast growth factor 19 (FGF19).
Wu X; Ge H; Lemon B; Vonderfecht S; Baribault H; Weiszmann J; Gupte J; Gardner J; Lindberg R; Wang Z; Li Y
Proc Natl Acad Sci U S A; 2010 Aug; 107(32):14158-63. PubMed ID: 20660733
[TBL] [Abstract][Full Text] [Related]
2. FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation.
Wu X; Ge H; Lemon B; Vonderfecht S; Weiszmann J; Hecht R; Gupte J; Hager T; Wang Z; Lindberg R; Li Y
J Biol Chem; 2010 Feb; 285(8):5165-70. PubMed ID: 20018895
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a FGF19 variant with altered receptor specificity revealed a central role for FGFR1c in the regulation of glucose metabolism.
Ge H; Baribault H; Vonderfecht S; Lemon B; Weiszmann J; Gardner J; Lee KJ; Gupte J; Mookherjee P; Wang M; Sheng J; Wu X; Li Y
PLoS One; 2012; 7(3):e33603. PubMed ID: 22457778
[TBL] [Abstract][Full Text] [Related]
4. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.
Gallego-Escuredo JM; Gómez-Ambrosi J; Catalan V; Domingo P; Giralt M; Frühbeck G; Villarroya F
Int J Obes (Lond); 2015 Jan; 39(1):121-9. PubMed ID: 24813368
[TBL] [Abstract][Full Text] [Related]
5. Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity.
Agrawal A; Parlee S; Perez-Tilve D; Li P; Pan J; Mroz PA; Kruse Hansen AM; Andersen B; Finan B; Kharitonenkov A; DiMarchi RD
Mol Metab; 2018 Jul; 13():45-55. PubMed ID: 29789271
[TBL] [Abstract][Full Text] [Related]
6. Differential receptor selectivity of the FGF15/FGF19 orthologues determines distinct metabolic activities in
Hansen AMK; Vienberg SG; Lykkegaard K; Zhao X; Tingqing G; Han D; Zhang X; Thøgersen H; Sass-Ørum K; Tagmose T; Raun K; Andersen B
Biochem J; 2018 Sep; 475(18):2985-2996. PubMed ID: 30127091
[TBL] [Abstract][Full Text] [Related]
7. Role of fibroblast growth factor 19 in the control of glucose homeostasis.
Schaap FG
Curr Opin Clin Nutr Metab Care; 2012 Jul; 15(4):386-91. PubMed ID: 22617565
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21.
Kurosu H; Choi M; Ogawa Y; Dickson AS; Goetz R; Eliseenkova AV; Mohammadi M; Rosenblatt KP; Kliewer SA; Kuro-O M
J Biol Chem; 2007 Sep; 282(37):26687-26695. PubMed ID: 17623664
[TBL] [Abstract][Full Text] [Related]
9. Fundamentals of FGF19 & FGF21 action in vitro and in vivo.
Adams AC; Coskun T; Rovira AR; Schneider MA; Raches DW; Micanovic R; Bina HA; Dunbar JD; Kharitonenkov A
PLoS One; 2012; 7(5):e38438. PubMed ID: 22675463
[TBL] [Abstract][Full Text] [Related]
10. FGF19, FGF21, and an FGFR1/β-Klotho-Activating Antibody Act on the Nervous System to Regulate Body Weight and Glycemia.
Lan T; Morgan DA; Rahmouni K; Sonoda J; Fu X; Burgess SC; Holland WL; Kliewer SA; Mangelsdorf DJ
Cell Metab; 2017 Nov; 26(5):709-718.e3. PubMed ID: 28988823
[TBL] [Abstract][Full Text] [Related]
11. FGF19 subfamily members: FGF19 and FGF21.
Dolegowska K; Marchelek-Mysliwiec M; Nowosiad-Magda M; Slawinski M; Dolegowska B
J Physiol Biochem; 2019 Jun; 75(2):229-240. PubMed ID: 30927227
[TBL] [Abstract][Full Text] [Related]
12. Serum concentrations of fibroblast growth factors 19 and 21 in women with gestational diabetes mellitus: association with insulin resistance, adiponectin, and polycystic ovary syndrome history.
Wang D; Zhu W; Li J; An C; Wang Z
PLoS One; 2013; 8(11):e81190. PubMed ID: 24260557
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-34a and Impaired FGF19/21 Signaling in Obesity.
Fu T; Kemper JK
Vitam Horm; 2016; 101():175-96. PubMed ID: 27125742
[TBL] [Abstract][Full Text] [Related]
14. Minireview: Roles of Fibroblast Growth Factors 19 and 21 in Metabolic Regulation and Chronic Diseases.
Zhang F; Yu L; Lin X; Cheng P; He L; Li X; Lu X; Tan Y; Yang H; Cai L; Zhang C
Mol Endocrinol; 2015 Oct; 29(10):1400-13. PubMed ID: 26308386
[TBL] [Abstract][Full Text] [Related]
15. Dynamic Changes in Circulating Endocrine FGF19 Subfamily and Fetuin-A in Response to Intralipid and Insulin Infusions in Healthy and PCOS Women.
Ramanjaneya M; Bensila M; Bettahi I; Jerobin J; Samra TA; Aye MM; Alkasem M; Siveen KS; Sathyapalan T; Skarulis M; Atkin SL; Abou-Samra AB
Front Endocrinol (Lausanne); 2020; 11():568500. PubMed ID: 33101202
[No Abstract] [Full Text] [Related]
16. FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss.
Gómez-Ambrosi J; Gallego-Escuredo JM; Catalán V; Rodríguez A; Domingo P; Moncada R; Valentí V; Salvador J; Giralt M; Villarroya F; Frühbeck G
Clin Nutr; 2017 Jun; 36(3):861-868. PubMed ID: 27188262
[TBL] [Abstract][Full Text] [Related]
17. Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB.
Yang C; Jin C; Li X; Wang F; McKeehan WL; Luo Y
PLoS One; 2012; 7(3):e33870. PubMed ID: 22442730
[TBL] [Abstract][Full Text] [Related]
18. Curtailing FGF19's mitogenicity by suppressing its receptor dimerization ability.
Niu J; Zhao J; Wu J; Qiao G; Gu J; Zhou C; Li Q; Ying L; Wang D; Lin H; Li X; Mohammadi M; Huang Z
Proc Natl Acad Sci U S A; 2020 Nov; 117(46):29025-29034. PubMed ID: 33144503
[TBL] [Abstract][Full Text] [Related]
19. Dual actions of fibroblast growth factor 19 on lipid metabolism.
Wu X; Ge H; Baribault H; Gupte J; Weiszmann J; Lemon B; Gardner J; Fordstrom P; Tang J; Zhou M; Wang M; Li Y
J Lipid Res; 2013 Feb; 54(2):325-32. PubMed ID: 23204296
[TBL] [Abstract][Full Text] [Related]
20. An Overview of FGF19 and FGF21: The Therapeutic Role in the Treatment of the Metabolic Disorders and Obesity.
Babaknejad N; Nayeri H; Hemmati R; Bahrami S; Esmaillzadeh A
Horm Metab Res; 2018 Jun; 50(6):441-452. PubMed ID: 29883971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
